Jaguar Health JAGX
NASDAQ JAGX
$0.42 -0.02 (-4.61%)
As of: Nov 10, 2026 · 3:43 PM EST

Jaguar Health (JAGX) Current Leases (2017 - 2018)

Updated

Jaguar Health (JAGX) reported Current Leases of $3,240 for Q1 2018, down 29.3% from the prior quarter.

Analysis

Jaguar Health (JAGX) Current Leases (2017 - 2018) Analysis & Trends

At the end of FY2017, Jaguar Health posted Current Leases of $4,584.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Jaguar Health 22,951.90 -15.54 Mn 194,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 3,240.00
Dec 31, 2017 4,584.00
API Access

Jaguar Health Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=JAGX&period=max&api_key=YOUR_API_KEY